Integrating evolutionary trade-off models from antibiotic resistance studies with equilibrium concepts beyond unilateral deviation will identify coalition-driven resistance pathways that are otherwise inaccessible to standard fitness landscape analyses.
Adversarial Debate Score
60% survival rate under critique
Expert panel critique
Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.
Supporting Research Papers
- Exploiting evolutionary trade-offs to combat antibiotic resistance
Antibiotic resistance frequently evolves through fitness trade-offs in which the genetic alterations that confer resistance to a drug can also cause growth defects in resistant cells. Here, through ex...
- The Fitness Cost of Antibiotic Resistance: A Critical Factor in Bacterial Adaptation
Antibiotic resistance often incurs fitness costs that can impair bacterial growth, competitiveness, or adaptability in drug-free environments. However, these disadvantages are frequently offset by com...
- Identification of Evolutionary Trade‐Offs Associated With High‐Level Colistin Resistance in Acinetobacter baumannii
Colistin (COL) belongs to the polymyxin group of drugs, which possesses a positive charge and interacts with lipopolysaccharide (LPS) of Gram‐negative bacterial outer membranes. Acinetobacter baumanni...
- Pleotropic Effects of Antibiotic Resistance Mutation
Antibiotic resistance mutations (AMRs) alter the phenotypic (physical) characteristics of an organism, which may result in enhanced fitness under antibiotic stress. However, these mutations often infe...
- Identification of Evolutionary Trade-Offs Associated with High-Level Colistin Resistance in Acinetobacter baumannii
Colistin (COL) belongs to the polymyxin group of drugs which possesses a positive charge and interacts with lipopolysaccharide (LPS) of Gram-negative bacterial outer membrane. Additionally, it can pen...
Formal Verification
Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.
This discovery has a Claude-generated validation package with a full experimental design.
Precise Hypothesis
Integrating evolutionary trade-off models from antibiotic resistance studies with coalition-based equilibrium concepts (i.e., Nash equilibria permitting coordinated, multi-genotype deviations) will reveal coalition-driven resistance pathways in microbial fitness landscapes that cannot be detected by standard models limited to unilateral deviations.
- No coalition-driven resistance pathways are found that are inaccessible to standard unilateral deviation analyses.
- Coalition-based models fail to improve predictive accuracy for resistance evolution compared to standard approaches.
- Empirical validation fails: predicted coalition-driven pathways are not observed in real or simulated data.
- Integration of coalition-based equilibria into trade-off models does not yield statistically significant new insights (ΔAUC < 0.02 versus baseline).
Spine & Adversarial ReadReady for validation
“Integrating coalition-based equilibrium concepts into evolutionary trade-off models of antibiotic resistance uncovers resistance pathways inaccessible to standard unilateral analyses.”
- highCoalition-based deviations may not represent biologically plausible evolutionary events in microbial populations, as simultaneous multiple mutations are exceedingly rare.The methodology limits coalition size to k=2–3 and requires empirical validation in real datasets; if coalition pathways are not observed, the hypothesis will be falsified.
- mediumThe choice of datasets and models (e.g., E. coli, β-lactamase) may not generalize to other microbes or resistance mechanisms.The EVP specifies extensibility to other datasets; initial validation focuses on well-characterized systems for feasibility.
- mediumWhy use coalition equilibria rather than alternative multi-locus evolutionary models (e.g., epistasis-aware Markov models)?Coalition equilibria expressly model coordinated, not merely interacting, deviations; this approach is justified by the hypothesis but could be compared against other models in future work.
Experimental Protocol
- Select a model organism with well-characterized antibiotic resistance evolution (e.g., Escherichia coli).
- Obtain a high-resolution fitness landscape constructed from combinatorial resistance genotypes (e.g., from deep mutational scanning datasets).
- Construct two predictive models: a. Baseline: Evolutionary trade-off model using standard fitness landscape analysis (unilateral deviations only). b. Experimental: Integrate coalition-based equilibrium concepts (e.g., Strong Nash equilibria) into the trade-off model.
- Simulate evolutionary trajectories under both models, tracking accessible resistance pathways.
- Empirically validate model predictions using (a) historical laboratory evolution data, and (b) time-resolved clinical isolate datasets.
- Quantitatively compare the pathways identified by each model, and assess empirical overlap.
- Deep mutational scanning data for resistance genes (e.g., β-lactamase in E. coli; see Stiffler et al., 2015, Cell).
- Longitudinal laboratory evolution datasets (e.g., LTEE, Pseudomonas/E. coli resistance evolution).
- Clinical isolate resistance genotype/phenotype datasets (e.g., NCBI Pathogen Detection Project).
- Standard fitness landscape representations, e.g., genotype × fitness matrices.
- The coalition-based model identifies at least one resistance pathway per dataset not found by the unilateral model.
- Empirical validation shows that ≥20% of coalition-driven pathways are observed in real evolution data, compared to ≤5% for random or baseline models.
- Predictive accuracy (AUC or recall for resistance endpoint prediction) is improved by ≥0.02 over baseline.
- Statistical significance of improvement p < 0.05.
- No additional pathways identified by coalition-based model.
- Empirical validation rate of coalition-driven pathways does not exceed random expectation (p ≥ 0.05).
- No statistically significant improvement in predictive accuracy.
- Model fails to converge or is computationally infeasible for the chosen landscape.
80
GPU hours
60d
Time to result
$3,200
Min cost
$9,000
Full cost
ROI Projection
- High for pharmaceutical R&D (antibiotic pipeline prioritization, resistance forecasting).
- Valuable for public health surveillance (improved prediction of resistance emergence).
- Research tool for evolutionary biology and computational genomics fields.
Implementation Sketch
# High-level pseudocode/architecture for experimental validation # 1. Setup import numpy as np from coalition_equilibrium import compute_strong_nash, coalition_enumerate from fitness_landscape import load_fitness_matrix, simulate_evolution from validation_utils import match_paths, roc_auc_score # Load datasets fitness_matrix = load_fitness_matrix('beta_lactamase_DMS.csv') lab_trajs = load_lab_evolution_data('lab_evolution.csv') clinical_trajs = load_clinical_data('clinical_isolates.csv') # 2. Baseline Model: Unilateral Deviations def find_unilateral_paths(fitness_matrix, start_genotype, end_genotype): # Greedy ascent: only single-mutation steps paths = [] for path in hill_climb_paths(fitness_matrix, start_genotype, end_genotype, max_steps=10): paths.append(path) return paths # 3. Coalition Model: Multi-genotype deviations def find_coalition_paths(fitness_matrix, start_genotype, end_genotype, max_coalition_size=3): # Enumerate all k-tuple mutations (k = 2,3) at each step coalition_paths = [] for coalition in coalition_enumerate(fitness_matrix, start_genotype, end_genotype, max_k=max_coalition_size): if compute_strong_nash(fitness_matrix, coalition): coalition_paths.append(coalition) return coalition_paths # 4. Simulation Loop results = [] for start_genotype in representative_starting_points(fitness_matrix): unilat_paths = find_unilateral_paths(fitness_matrix, start_genotype, target_resistance_genotype) coal_paths = find_coalition_paths(fitness_matrix, start_genotype, target_resistance_genotype) results.append({'start': start_genotype, 'unilat': unilat_paths, 'coal': coal_paths}) # 5. Validation Against Empirical Data def validate_paths(predicted_paths, empirical_trajs): match_rate = match_paths(predicted_paths, empirical_trajs) auc = roc_auc_score(predicted_paths, empirical_trajs) return match_rate, auc unilat_match, unilat_auc = validate_paths([r['unilat'] for r in results], lab_trajs + clinical_trajs) coal_match, coal_auc = validate_paths([r['coal'] for r in results], lab_trajs + clinical_trajs) # 6. Statistical Analysis improvement = coal_auc - unilat_auc significant = permutation_test(coal_auc, unilat_auc, n=1000, alpha=0.05) # 7. Output print(f"Unilateral AUC: {unilat_auc}, Coalition AUC: {coal_auc}, Improvement: {improvement}, Significant: {significant}") # All code, environments, and data are archived for reproducibility. # Controls: # - Randomized path generation as a negative control. # - Bootstrapped sampling to assess robustness. # Output artifacts: # - Tables of identified pathways (with overlap/novelty scores) # - Validation metrics (AUC, recall, p-values) # - Code archive and parameter log
- After data prep: abort if <1,000 non-redundant genotypes available.
- After baseline modeling: abort if no difference in pathway count between models.
- After empirical validation: abort if match rate for coalition pathways ≤ random expectation.